OYSTER POINT IS NOW A PART OF VIATRIS CLICK HERE

Oyster Point Pharma ONSET-2 Phase 3 Study Results and First Quarter 2020 Earnings Conference Call

May 11, 2020 at 8:00 AM EDT

Shareholder Tool